Jonathan Poole
CIK 1604689 · CFO · last filed 2026-06-01
Jonathan Poole is a CFO who has filed 14 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for ACAD, was dated Jun 1, 2026. Across all open-market trades the lifetime net is −$271.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $42.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$42.4K
3
14
-$271.5K
Holdings By Company
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-01 | ACAD | Mixed | +2,010 | $0 | EDGAR |
| 2026-03-20 | ACAD | Grant (A) | — | $0 | EDGAR |
| 2020-01-30 | EVLO | Grant (A) | — | $0 | EDGAR |
| 2019-01-16 | EVLO | Grant (A) | — | $0 | EDGAR |
| 2018-05-10 | EVLO | Grant (A) | — | $0 | EDGAR |
| 2018-02-12 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-07-24 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Mixed | — | -$130.9K | EDGAR |
| 2017-05-10 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Mixed | +22,034 | -$61.9K | EDGAR |
| 2017-03-01 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-11-09 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Buy (P) | +7,000 | $23.4K | EDGAR |